Challenges of systematic reviewing integrative health care. by Coulter, Ian D et al.
UCLA
UCLA Previously Published Works
Title
Challenges of systematic reviewing integrative health care.
Permalink
https://escholarship.org/uc/item/2x4538m2
Journal
Integrative medicine insights, 8(8)
ISSN
1177-3936
Authors
Coulter, Ian D
Khorsan, Raheleh
Crawford, Cindy
et al.
Publication Date
2013
DOI
10.4137/imi.s11570
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Integrative Medicine Insights 2013:8 19–28
doi: 10.4137/IMI.S11570
This article is available from http://www.la-press.com.
© the author(s), publisher and licensee Libertas Academica Ltd.
This is an open access article published under the Creative Commons CC-BY-NC 3.0 license.
Open Access
Full open access to this and 
thousands of other papers at 
http://www.la-press.com.
Integrative Medicine Insights
S h o r T  r e v I e w
Integrative Medicine Insights 2013:8 19
challenges of systematic Reviewing Integrative Health care
Ian D. Coulter1–3, raheleh Khorsan4,5, Cindy Crawford6 and An-Fu hsiao7,8
1rAND Corporation, Santa Monica, CA, USA. 2University of California Los Angeles, Los Angeles, CA, USA. 
3Southern California University of health Sciences, whittier, CA, USA. 4Military Medical research and Integrative 
Medicine, Samueli Institute, Corona Del Mar, CA, USA. 5Department of Planning, Policy and Design, School of Social 
ecology, University of California Irvine, Irvine, CA, USA. 6Samueli Institute, Alexandria, vA, USA. 7vA Long Beach 
healthcare System, Long Beach, CA, USA. 8Center for health Policy research, University of California, Irvine, CA, USA.
Corresponding author email: coulter@rand.org
Abstract: This article is based on an extensive review of integrative medicine (IM) and integrative health care (IHC). Since there is 
no general agreement of what constitutes IM/IHC, several major problems were identified that make the review of work in this field 
problematic.In applying the systematic review methodology, we found that many of those captured articles that used the term integra-
tive medicine were in actuality referring to adjunctive, complementary, or supplemental medicine. The objective of this study was to 
apply a sensitivity analysis to demonstrate how the results of a systematic review of IM and IHC will differ according to what inclusion 
criteria is used based on the definition of IM/IHC. By analyzing 4 different scenarios, the authors show that, due to unclear usage of 
these terms, results vary dramatically, exposing an inconsistent literature base for this field.
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Introduction
As an emerging field, integrative health care (IHC), 
also called integrative medicine (IM), faces the 
problem of a widely accepted and applied definition. 
In an earlier publication,1,2 the authors noted that the 
definitions for IM/IHC can range from the definition 
of IHC as simply incorporating complementary and 
alternative medicine (CAM) into biomedicine, to 
the notion that IHC constitutes a new form of medi-
cal practice. While the articles in the Khorsan et al1 
systematic review used the term integrative, the 
terminology is not well defined in the literature. In 
addition, The Khorsan et al systematic review report 
used the guiding principle for our inclusion criteria 
that IHC research is the study of the incorporation of 
CAM with biomedicine as a collaborative and inte-
gral part of the health care system, that is, the inte-
gration of conventional (allopathic) medicine and 
CAM, involving shared management of the patient, 
shared patient care, shared practice guidelines, and 
shared common values and goals to treat the well-
being of the whole person.1,3 In applying this sys-
tematic review methodology, the authors found that 
many of those captured articles that used the term 
integrative medicine were in actuality referring to 
adjunctive, complementary, or supplemental medi-
cine. By adjunctive we mean that the CAM therapy 
is used in addition to allopathic care but as supple-
mental or complementary to the biomedical care. 
Adjunctive therapy in this sense has no requirement 
about joint management, collaboration, or a partner-
ship between providers. It simply means the patient 
is using CAM and biomedicine  concurrently. Even 
where the providers are cognizant of the use of both 
forms of therapy, the CAM is seen primarily as 
adjunctive. This would be the case in cancer treat-
ment, for example, where acupuncture is used to 
treat nausea arising from the use of  chemotherapy, 
where clearly the primary therapy for the actual 
cancer is chemotherapy. We are making no implied 
judgment here about the worth of adjunctive care 
or whether this is a positive role for CAM to play, 
we are concerned only with whether the definition 
of IHC/IM as currently being proposed excludes or 
includes adjunctive care.
The authors of the systematic review discovered 
the lack of a clear definition and clarity of the term 
integrative health care medicine/integrative medicine 
(IHC/IM), and the absence of taxonomy for models 
of IHC/IM make it very difficult to efficiently con-
duct systematic reviews of this field at this time. 
Depending on what definition is used, the amount 
of literature can be either very small or very large. 
If IM means genuine cooperation and comanage-
ment of patients, then in our previous article, of the 
11,591 original citations captured in the literature 
under the category integrative, most were not truly 
integrative. We reviewed 20 studies that we deemed 
eligible for qualitative synthesis, which were fur-
ther reduced to 6 articles that met the strict inclu-
sion criteria of being randomized controlled  trials. 
Excluded from that review were articles that used 
the term integrative but actually were referring to 
adjunctive therapy (n = 52) as we define it. Please see 
 Figure 1 that is published elsewhere for a description 
of identified studies.1
In this article we examine further the type of con-
fusion that can occur in systematic reviews in this 
field depending on whether adjunctive therapy is 
included in the definition for IHC and what type of 
adjunctive therapy is excluded if IHC is defined as 
in the more expansive definition as given by such 
writers as boon et al.1,3 They provide the follow-
ing working definition. Writers such as Boon et al 
give the following working definition for IHC as the 
combination of an interdisciplinary, nonhierarchical 
blending of both CAM and conventional medicine 
that employs a collaborative team approach guided 
by consensus building, mutual respect, and a shared 
vision of health through a partnership of patient and 
practitioners to treat the whole person by synergisti-
cally combining therapies and services in a manner 
that exceeds the collective effect of the individual 
practice.1,3
Bell et al4 define IHC as “a transformative sys-
tem represented by a higher-order system of systems 
of care that emphasizes wellness and healing of the 
entire person (bio-psycho-socio-spiritual dimen-
sions) as primary goals, drawing on best both con-
ventional and CAM approaches in the context of a 
supportive and effective physician- patient relation-
ship.” Stumpf et al5 refer to the malleable definitions 
of IHC as “one first step towards understanding the 
phenomenon.” But it is misleading to term what is 
happening in the field of IHC/IM if, in fact, what is 
“occur ring “more closely resembles assimilation of 
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CAM” by biomedicine [rather] than true accultura-
tion.”5 As we will show in this report, the term inte-
grative cannot be taken at face value as the definition 
because we believe it to mean (and it could, in fact, 
mean) adjunctive therapy, which is something quite 
different from integrative as we will try to portray. 
 Therefore, systematic review methodology is chal-
lenged by the term integrative when trying to deter-
mine the quantity, quality, and effectiveness of IHC 
practices.
In this article, we have chosen to compare articles 
that met the very expansive definition of IHC/IM as 
we define it with articles that would meet the defi-
nition if it included adjunctive therapy. The objec-
tive of this article is to apply a sensitivity analysis 
to explore how the results of a systematic review of 
IHC/IM differ according to what inclusion criteria 
are used based on the definition of IHC/IM. The pri-
mary purpose of this article is to examine what is lost 
or gained depending on the type of studies included 
or excluded.
Methods
We describe the full methodology of this systematic 
review elsewhere.1,2 In brief, we searched PubMed, 
Allied and Complementary Medicine (AMED), 
BIOSIS Previews, EMBASE, the entire Cochrane 
Library, MANTIS, Social SciSearch, SciSearch Cited 
Ref Sci, PsychInfo, CINAHL, and NCCAM grantee 
publications listings, from database inception to 
May 2009, as well as searches of the gray literature. 
Available studies published in English language were 
included. Three independent reviewers rated each 
article and assessed the methodological quality of 
studies using the Scottish Intercollegiate Guidelines 
Network (SIGN 50).6 There were no available sys-
tematic reviews or meta-analyses published that met 
our inclusion criteria. Our initial search terms were 
Integrat* and Medicine; Integrat* and Health* (for 
health care); multidisciplinary care; complementary 
or alternative and conventional medicine or health 
care; and delivery of health care and integrat*. Our 
initial search yielded 11,591 citations. Of these, only 
11591 records identified through
database searching and through
other sources Sept 1, 2007
300 records identified through database
and through other sources searching
Sept 1, 2007–May, 2009
11231 excluded
studies 11891 records screened
660 full text articles assessed
for eligibility
126 RCTs
21 systematic reviews
106 RCTs excluded
21 systematic reviews excluded
20 studies
included in
qualitative
synthesis
Categories of excluded
studies
Categories of excluded studies
Categories for other studies
included in the bibliography • 66 not applicable to
   western health care
   setting
• 6 database
• 7 basic science/mechanistic studies
• 14 conference proceedings
• 56 editorial
• 107 animal study
• 10859 not relevant
• 182 duplicates
• 5 guidelines
• 10 position consensus statements
• 11 cost effectiveness/utilization studies
• 21 reviews
• 30 descriptive studies
• 34 program evaluations
• 38 business models
• 75 observation studies/case studies
• 98 conceptual/philosophical
• 121 strategies for integrative health care
• 157 practice mode studies
• 4 full text articles
   irretrievable
• 5 studies that tested
   herbs/supplements
• 52 adjunctive therapy
   studies
Figure 1. Systematic review flow chart.
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660 were judged to be relevant to the purpose of our 
search and were coded into their respective categories 
of study design.
We originally published an article reporting only 
on the randomized controlled trials and controlled 
clinical trials, which amounted to 6 articles that 
truly met the inclusion criteria that fit our definition 
of IM. In order to compare definitions of adjunc-
tive versus IHC/IM for those studies in our original 
systematic review, we subjectively chose 4 articles. 
Two of the 4 articles were examples of IHC/IM.7–10 
One of the 2 was included in our systematic review 
(met the expansive definition) while the other that 
we described contained integrative medicine in its 
title but involved adjunctive or complementary 
medicine in its methodology. In addition, 2 of the 
4 articles were examples of adjunctive or comple-
mentary medicine. However, 1 of the 2 had adjunc-
tive or complementary medicine in its title, but 
was integrative in its methodology (See Tables 1 
and 2).
Results
“Complementary therapies” was a term that was 
introduced to MeSH terms (Medical Subject Head-
ings) for MEDLINE in 1986 and redefined in 
2002 at the National Library of Medicine (NLM). 
In MeSH, the controlled vocabulary thesaurus, 
complementary therapies are defined as “therapeu-
tic practices which are not currently considered 
an integral part of conventional allopathic medi-
cal practice.” They may lack biomedical explana-
tions, but as they become better researched, some 
(physical therapy modalities, diet, and acupunc-
ture) become widely accepted, whereas others 
(humors and radium therapy) quietly fade away, 
yet are important historical footnotes. Therapies are 
termed as complementary when used in addition 
to conventional treatments and as alternative when 
used instead of conventional treatment. The MeSH 
subject tree includes acupuncture, holistic care, 
midbody therapies, musculoskeletal manipulations, 
and so on. The term integrative medicine (IM) was 
introduced as a MeSH term in 2009. IM is defined 
by MeSH as the “discipline concerned with using 
the combination of conventional (allopathic) medi-
cine and alternative medicine to address the biolog-
ical, psychological, social, and spiritual aspects of 
health and illness.” When we searched PubMed in 
2011 for the term integrative medicine, we found 
5235 total citations of which 246 were classified 
as clinical trials. In our original systematic review, 
we found that the majority of the citations from our 
search results included study citations for adjunc-
tive therapies and complementary therapies. Below 
we examine the challenge faced when deciding if an 
article is truly about IM/IHC or whether it is about 
adjunctive therapies or complementary medicine.
Cases of adjunctive therapy/
complementary medicine
We examine first the case where a research article 
claims its intervention to be IM/IHC but turns out to 
be adjunctive or complementary (see Table 1).
As noted previously, we found that in our system-
atic review the definitions of integrative healthcare 
run the gamut from those who see it as simply the 
integration of CAM in some form of relationship with 
biomedicine (usually institutional and sometimes 
referred to as adjunctive therapy or complementary/
Table 1. Studies matrix.
Integrative title Adjunctive title
Integrative  
intervention
edelman D, oddone eZ, Liebowitz rS,  
Yancy wS Jr, olsen MK, Jeffreys AS,  
Moon SD, harris AC, Smith LL, Quillian- 
wolever re, Gaudet Tw. A multidimensional  
integrative medicine intervention to improve  
cardiovascular risk. J Gen Intern Med.  
Jul 2006;21(7):728–34.
Krucoff Mw, Crater Sw, Green CL, Maas AC, Seskevich Je, 
Lane JD, Loeffler KA, Morris K, Bashore TM, Koenig HG. 
Integrative noetic therapies as adjuncts to percutaneous 
intervention during unstable coronary syndromes: 
Monitoring and Actualization of Noetic Training (MANTrA) 
feasibility pilot. Am Heart J. Nov 2001;142(5):760–9.
Adjunctive  
intervention
Narahari Sr, Aggithaya MG, Prasanna KS,  
Bose KS. An integrative treatment for lower  
limb lymphedema (elephantiasis). J Altern  
Complement Med. Feb 2010;16(2):145–9.
Berman BM, Lao L, Langenberg P, Lee wL, Gilpin AM, 
hochberg MC. effectiveness of acupuncture as adjunctive 
therapy in osteoarthritis of the knee: a randomized, controlled 
trial. Ann Intern Med. Dec 21, 2004;141(12):901–10.
reviewing integrative health care
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combination medicine)11 to those who propose that it 
is a new form of medicine as a combination of an 
interdisciplinary, nonhierarchical blending of both 
CAM and conventional medicine that employs a col-
laborative team approach guided by consensus build-
ing, mutual respect, and a shared vision of health 
through a partnership of patient and practitioners to 
treat the whole person by synergistically combining 
therapies and services in a manner that exceeds the 
collective effect of the individual practice.2
In order to compare examples of adjunctive therapy 
versus IHC/IM, we chose 2 studies from our systematic 
review. Both studies were considered adjunctive in their 
methodology, were tagged as adjunctive/ complementary 
therapy based on our definition of IHC/IM above and 
were excluded from our systematic review.7,8 How-
ever, 1 of the studies did pass our secondary review7 
when its abstract was reviewed by 2 reviewers and was 
deemed inclusionary because it included the phrase 
integrative treatment in its title and abstract7 while the 
other did not.8 The study by Narahari et al7 combined 
traditional ayurvedic practices with biomedicine to 
treat lymphedema caused by lymphatic filariasis (LF). 
The study states that it followed an integrative pro-
tocol. However, it is not clear how patients received 
standard biomedical care in addition to ayurvedic 
practices. We posit that if patients had received both 
ayurvedic practices and standard care, incorporation 
of CAM into conventional medicine without a joint 
management does not constitute IM/IHC. Indeed, this 
study states “patients with LF are examined by a team 
of biomedical, Ayurvedic, and yoga medicine experts, 
who assess both patient and pathology from all three 
perspectives,”7 but the use of CAM as an adjunctive 
treatment to conventional care without a unifying para-
digm may lead to worse outcomes because the selected 
CAM modality may adversely interact with conven-
tional modality and vice versa.7,8
The second study, by Berman et al, tested the 
efficacy of acupuncture for reducing the pain and 
dysfunction of osteoarthritis compared with sham 
acupuncture. Similar to the above study, patients con-
tinued to receive biomedical care during the study 
and were allowed to receive their usual medications.8 
The objective of this study was to see if acupuncture 
can have a vital role in adjunctive therapy as part of 
a multidisciplinary integrative approach to treating 
symptoms related to knee osteoarthritis.8 There was 
little to no joint management, collaboration, and/or 
partnership between providers giving treatment. In 
addition, an IM/IHC philosophy or process was not 
incorporated in this study.
The 2 studies described above represent instances 
of complementary therapy or adjunctive therapy that 
are close to conforming to the definition of ICH/IM, 
but for both studies, we were unable to find integra-
tive management of care as defined by our systematic 
review and, therefore, exclude both studies from our 
systematic review.
Two cases of integrative health care
The second situation is where there was IM/IHC, that 
is, the incorporation of CAM with biomedicine as a 
collaborative and integral part of the health care. This 
involved the integration of conventional (allopathic) 
medicine and CAM and involved shared manage-
ment of the patient, shared patient care, shared prac-
tice guidelines, and shared common values and goals 
to treat the well-being of the whole person.
Two studies met our inclusion criteria for IM/
IHC.9,10 The Edelman et al study on multidimen-
sional IHC interventions to improve cardiovascular 
risk, defines integrative medicine as “an individu-
alized, patient-centered approach to health, com-
bining a whole-person model with evidence- based 
medicine.”9 Their multidimensional intervention was 
guided by IM/IHC principles and tested the effect 
of personalized health planning (PHP) involving the 
“use of patient-centered, individualized therapeutic 
approaches.”9 This study incorporated a transdis-
ciplinary (nonhierarchical blending) approach by 
employing a collaborative team guided by consen-
sus building and a shared vision of health through a 
partnership of patient and practitioners. In essence, 
IM/IHC should aim to treat the whole person by syn-
ergistically combining therapies and services in a 
manner that exceeds the collective effect of the indi-
vidual practice. Therefore, Edelman et al labeled this 
study as both integrative in title and integrative in 
intervention.
Like the Edelman et al study, the study by Krucoff 
et al10 tested an IM/IHC intervention. Unlike  Edelman 
et al, Krucoff et al state in their title that they examined 
integrative noetic therapies as adjuncts to percutane-
ous intervention during unstable coronary syndromes. 
However, both studies’ primary  objective was to test 
Coulter et al
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Table 2. Study characteristics.
citation population  
description
Description of intervention Description of control Intervention duration  
and time-points
primary outcomes  
assessed/results
Adverse events sign  
score*
Adjunctive title and adjunctive intervention 
Berman  
et al.  
(2004)
570 patients with  
osteoarthritis of the  
knee (mean age [±SD],  
65.5 ± 8.4 years).
Acupuncture: True acupuncture  
sessions 
sham acupuncture: Procedure was 
given on the same schedule as the 
experimental group and used the same 
active needle placements, except actual 
insertion did not occur at these 9 points. 
sham points: Acupuncturists inserted 
2 needles into the sham points and 
then immediately applied 2 pieces of 
adhesive tape next to the needles.
education control: The education–
attention control consisted of 6 two 
hour group sessions based on the 
Arthritis Self-Management Program 
and taught by an experienced, Arthritis 
Foundation–trained patient education 
specialist.
23 true acupuncture sessions  
over 26 weeks gradually tapering  
treatment according to the following  
schedule: 8 weeks of 2 treatments  
per week followed by 2 weeks of  
1 treatment per week, 4 weeks of  
1 treatment every other week, and  
12 weeks of 1 treatment per month.
woMAC (Pain): while pain among  
participants who were receiving true  
acupuncture decreased more than in the  
sham group at all of the postbaseline  
assessments, this difference was not  
statistically significant at week 8. By week 14,  
the mean pain score had decreased by  
3.6 units in the acupuncture group (a 40%  
decrease from baseline) compared with -2.7  
in the sham group (P = 0.02). These  
differences remained at week 26 (P = 0.003).
woMAC (Function): The true acupuncture  
group’s improvement in function from  
baseline was significantly greater than that  
of the sham control group at weeks 8  
(P = 0.01), 14 (P = 0.04), and 26 (P = 0.009).  
A change of more than 12 units by  
14 weeks is an almost 40% improvement  
from baseline. 
Effect Size: ND
No adverse effects  
were associated  
with acupuncture.
++
Adjunctive title and integrative intervention 
Krucoff  
et al.  
(2001)
150 coronary disease  
patients (mean age  
[±SD], 63 ± ND years).
The Monitoring and Actualization  
of Noetic Training (MANTrA):  
Feasibility of applying
4 noetic therapies—stress  
relaxation, imagery, touch therapy,  
and prayer plus UC
UC: absence of any noetic treatment 
assignment by MANTrA protocol.
Baseline period was defined as the  
period from when the patient signed  
the consent form to the time the  
patient entered the catheterization  
laboratory. The physiologic stress  
period was defined as the period  
beginning with the arteriotomy in the  
catheterization laboratory until  
30 mins after the last contrast  
injection. The recovery period  
was defined as the period from  
30 mins after the last contrast  
injection through the time of hospital  
discharge. Long-term follow-up was  
defined as 6 months from the day of  
the PCI.
DUreL (Spirituality): There were no  
significant outcomes differences across  
these groups or when protocol noetic  
therapy was administered (NS).
SAQ (Anxiety): No differences between  
arms (NS). 
Adverse Periprocedural outcomes: There  
was a 25% to 30% absolute reduction in  
adverse periprocedural outcomes in patients  
treated with any noetic therapy compared  
with standard therapy. The lowest absolute  
complication rates were observed in  
patients assigned to off-site prayer.  
All mortality by 6-month follow-up was in  
the noetic therapies group. In patients with  
questionnaire scores indicating a high level  
of spiritual belief, a high level of personal  
spiritual activity, a low level of community- 
based religious involvement, or a high level  
of anxiety, noetic therapies appeared  
to show greater reduction in absolute  
in-hospital complication rates compared  
with standard therapy.
Effect Size: ND
ND ++
Integrative title and adjunctive intervention 
Narahari  
et al.  
(2010)
467 Llymphatic  
filariasis patients  
(mean age [±SD],  
ND ± ND years).
Biomedical, Ayurvedic,  
and yoga medicine
ND Baseline, 14th day, 45th day,  
and 90th day.
volume reduction: Treatment showed the  
volume reduction of 22.3% on 14th day,  
30.8% on 45th day, and 41.6% on 90th  
day of treatment for large limbs; for small  
limbs it was 11.1%, 24.3%, and 31.8%,  
respectively. Statistical significance ND. 
Contact dermatitis to  
nalpamaradi oil used  
for IMLD in five limbs.  
About 10% of patients  
developed scattered  
sterile pustules over  
the massaged limbs.
-
(Continued)
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Table 2. (Continued)
citation population  
description
Description of intervention Description of control Intervention duration  
and time-points
primary outcomes  
assessed/results
Adverse events sign  
score*
Integrative title and integrative intervention 
edelman  
et al.  
(2006)
154 cardiovascular  
risk outpatients  
(mean age [±SD],  
53.4 ± 4.8 years (UC)  
and 52.2 ± 5.2 years  
(PhP)).
Personalized health Plan (PhP)-  
The plan identified specific health  
behaviors important for each  
subject to modify; the choice of  
behaviors was driven both by  
cardiovascular risk reduction  
and the interests of each  
individual subject. Techniques  
used in implementation included  
mindfulness meditation, relaxation  
training, stress management,  
motivational techniques, and health  
education and coaching.
UC: absence of any noetic treatment 
assignment by PhP protocol.
Baseline, 5, and 10 months Framingham risk score (10-year risk of  
ChD): Baseline 10-year risk of ChD was  
11.1% for subjects randomized to UC  
(n = 77), and 9.3% for subjects randomized  
to PhP (n = 77). over 10 months of the  
intervention, ChD risk decreased to 9.8%  
for UC subjects and 7.8% for intervention  
subjects. Based on a linear mixed-effects  
model, there was a statistically significant  
difference in the rate of risk improvement 
between the 2 arms (P = 0.04). In secondary  
analyses, subjects in the PhP arm were  
found to have increased days of exercise  
per week compared with UC (3.7 vs. 2.4,  
P = 0.002), and subjects who were overweight 
on entry into the study had  
greater weight loss in the PhP arm  
compared with UC (P = 0.06).
ND +
notes: *SIGN checklist for rCTs and controlled clinical trials; ++Strong. All or most of the criteria have been fulfilled; +Article is neither exceptionally strong 
nor exceptionally weak; -Weak. Few or no criteria fulfilled.
Abbreviations: NS, Not Significant; Wk(s), week(s); Min, Minutes; Mon(s), Month(s); QoL, Quality of Life; hr, hour; eoT, end of Treatment; Se, Side 
effect; SD, Standard Deviation; ND, Not Described; DUreL, Duke University religion Index; SAQ, Spielberger anxiety questionnaires; woMAC, western 
ontario and McMaster Universities Arthritis Index.
the effect of holistic, patient-centered health planning 
and incorporation of team-oriented health care prac-
tices incorporating CAM interventions with biomedi-
cine as a collaborative and integral part of the health 
care system. We note that both studies refer to IHC 
as IM.
Discussion
The above cases illustrate the challenge facing 
those who wish to conduct systematic reviews on 
IM/IHC. As we note in an earlier article, this is 
reflective of the fact that this is an emerging field in 
which groups are vying to establish the field and its 
 definition. More recently, the University of Arizona 
Center for Integrative Medicine announced the cre-
ation of a formal specialty for medical doctors in 
IM.12 We see here a major shift in the original mean-
ing of IM as a type of practice bringing together 
complementary and alternative medicine (CAM) 
and biomedicine as a branch of allopathic medi-
cine. Using the term medicine implies hierarchy, 
while according to Boon et al’ the term integrative 
health care “employs a collaborative team approach 
guided by consensus building, mutual respect, and 
a shared vision of health care that permits each 
practitioner and the patient to contribute their own/
particular knowledge and skills within the context 
of a shared, synergistically-charged plan of care.”2 
Therefore, the term medicine for authors such as 
Boon et al is not an appropriate descriptor for this 
health care model.
The MeSH hierarchy scheme offered through the 
National Library of Medicine for Medline offers the 
correct definitions for the terms discussed in this 
report; however there is not a clear distinction of 
the intersection between these terms. One chal-
lenge is that IM is a new term recently introduced 
to MeSH and there is no structure that falls below 
this tree yet. By defining IM and applying the term 
correctly in the literature, we as researchers can 
help to dissect this problem of definitions and con-
tribute to building the MeSH tree and vocabulary 
for IM to dissolve these conflicting problems with 
definitions.
Until the field “sorts itself out,” and a common 
agreement about what the field really is emerges and 
what the correct term for the field is going to be, it will 
continue to pose a challenge for scholars,  particularly 
reviewing integrative health care
Integrative Medicine Insights 2013:8 27
Table 2. (Continued)
citation population  
description
Description of intervention Description of control Intervention duration  
and time-points
primary outcomes  
assessed/results
Adverse events sign  
score*
Integrative title and integrative intervention 
edelman  
et al.  
(2006)
154 cardiovascular  
risk outpatients  
(mean age [±SD],  
53.4 ± 4.8 years (UC)  
and 52.2 ± 5.2 years  
(PhP)).
Personalized health Plan (PhP)-  
The plan identified specific health  
behaviors important for each  
subject to modify; the choice of  
behaviors was driven both by  
cardiovascular risk reduction  
and the interests of each  
individual subject. Techniques  
used in implementation included  
mindfulness meditation, relaxation  
training, stress management,  
motivational techniques, and health  
education and coaching.
UC: absence of any noetic treatment 
assignment by PhP protocol.
Baseline, 5, and 10 months Framingham risk score (10-year risk of  
ChD): Baseline 10-year risk of ChD was  
11.1% for subjects randomized to UC  
(n = 77), and 9.3% for subjects randomized  
to PhP (n = 77). over 10 months of the  
intervention, ChD risk decreased to 9.8%  
for UC subjects and 7.8% for intervention  
subjects. Based on a linear mixed-effects  
model, there was a statistically significant  
difference in the rate of risk improvement 
between the 2 arms (P = 0.04). In secondary  
analyses, subjects in the PhP arm were  
found to have increased days of exercise  
per week compared with UC (3.7 vs. 2.4,  
P = 0.002), and subjects who were overweight 
on entry into the study had  
greater weight loss in the PhP arm  
compared with UC (P = 0.06).
ND +
notes: *SIGN checklist for rCTs and controlled clinical trials; ++Strong. All or most of the criteria have been fulfilled; +Article is neither exceptionally strong 
nor exceptionally weak; -Weak. Few or no criteria fulfilled.
Abbreviations: NS, Not Significant; Wk(s), week(s); Min, Minutes; Mon(s), Month(s); QoL, Quality of Life; hr, hour; eoT, end of Treatment; Se, Side 
effect; SD, Standard Deviation; ND, Not Described; DUreL, Duke University religion Index; SAQ, Spielberger anxiety questionnaires; woMAC, western 
ontario and McMaster Universities Arthritis Index.
for those doing systematic reviews. At the moment, 
depending on which definition is used, the field can 
be very large or quite modest. It also poses a problem 
for synthesis of the data from the studies. Is a study 
of adjunctive care really pertinent to assessing IM/
IHC? How are we to assess the outcomes from IM/
IHC unless we can first determine what it is that is 
being assessed? At the very least, this article suggests 
that we cannot rely on titles or abstracts as the basis 
for the search. The articles must be examined to see 
what, in fact, was done. One solution might be for 
journals to insist on certain criteria for calling a study 
one of IM/IHC.
We would therefore suggest there are at least 
three possible solutions: (1) authors can try to ensure 
that the term Integrative, both in their articles and 
in their titles, is used correctly, (2) editors can also 
insist that titles accurately describe what is in the 
article, and (3) the MeSH hierarchy scheme, offered 
through the National Library of Medicine for Med-
line, can develop a clear distinction of the intersec-
tion between the terms discussed in this article and 
develop a structure that falls below the “integrative 
tree.”
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